Ensysce Biosciences, Inc. (ENSC)

Ensysce Biosciences Revenue

Ensysce Biosciences had revenue of $3.42M in the quarter ending September 30, 2024, with 685.26% growth. This brings the company's revenue in the last twelve months to $4.42M, up 40.41% year-over-year. In the year 2023, Ensysce Biosciences had annual revenue of $2.23M, down -11.61%.

• Revenue (ttm): $4.42M
• Revenue Growth: +40.41%
• P/S Ratio: 0.79
• Revenue / Employee: $631,629
• Employees: 7
• Market Cap: 10.57M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.23M	-292.86K	-11.61%
Dec 31, 2022	2.52M	-1.01M	-28.54%
Dec 31, 2021	3.53M	-400.01K	-10.18%
Dec 31, 2020	3.93M	2.17M	122.86%
Dec 31, 2019	1.76M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.